The Impact of Vitamin D in Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study in Patients with Morbid Obesity

References

• Alshahrani F , Aljohani N . Vitamin D: deficiency, sufficiency and toxicity. Nutrients . 2013;5(9):3605–3616. doi:10.3390/nu5093605.24067388
   PubMed Web of Science ®Google Scholar
• DeLuca HF . Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr . 2004;80(6):1689S–1696S. doi:10.1093/ajcn/80.6.1689S 15585789
   PubMed Web of Science ®Google Scholar
• Cimini FA , Barchetta I , Carotti S , et al. Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease. World J Gastroenterol . 2017;23(19):3407–3417. doi:10.3748/wjg.v23.i19.3407 28596677
   PubMed Web of Science ®Google Scholar
• Wimalawansa SJ . Associations of vitamin D with insulin resistance, obesity, type 2 diabetes, and metabolic syndrome. J Steroid Biochem Mol Biol . 2018;175:177–189. doi:10.1016/j.jsbmb.2016.09.017 27662816
   PubMed Web of Science ®Google Scholar
• Prasad P , Kochhar A . Interplay of vitamin D and metabolic syndrome: a review. Diabetes Metab Syndr . 2016;10(2):105–112. doi:10.1016/j.dsx.2015.02.014 25813139
   PubMedGoogle Scholar
• Gaman MA , Epingeac ME , Diaconu CC , et al. Evaluation of oxidative stress levels in obesity and diabetes by the free oxygen radical test and free oxygen radical defence assays and correlations with anthropometric and laboratory parameters. World J Diabetes . 2020;11(5):193–201. doi:10.4239/wjd.v11.i5.193 32477455
   PubMed Web of Science ®Google Scholar
• Riobo Servan P . Obesity and diabetes. Nutr Hosp . 2013;28(Suppl 5):138–143. doi:10.3305/nh.2013.28.sup5.6929 24010754
   PubMed Web of Science ®Google Scholar
• Wang X , Li W , Zhang Y , et al. Association between vitamin D and non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: results from a meta-analysis. Int J Clin Exp Med . 2015;8(10):17221–17234.26770315
   PubMed Web of Science ®Google Scholar
• Targher G , Bertolini L , Scala L , et al. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis . 2007;17(7):517–524. doi:10.1016/j.numecd.2006.04.002 16928437
   PubMed Web of Science ®Google Scholar
• Bjelakovic G , Nikolova D , Bjelakovic M , et al. Vitamin D supplementation for chronic liver diseases in adults. Cochrane Database Syst Rev . 2017;11:CD011564. doi:10.1002/14651858.CD011564.pub2 29099543
   PubMed Web of Science ®Google Scholar
• Hosny S , Ali HM , Mohammed WA , El Ghannam MH . Study of relationship between total vitamin D level and NAFLD in a sample of Egyptian patients with and without T2DM. Diabetes Metab Syndr . 2019;13(3):1769–1771. doi:10.1016/j.dsx.2019.04.002 31235092
   PubMed Web of Science ®Google Scholar
• Keane JT , Elangovan H , Stokes RA , Gunton JE . Vitamin D and the liver-correlation or cause? Nutrients . 2018;10(4):498. doi:10.3390/nu10040496
   Web of Science ®Google Scholar
• Beilfuss A , Sowa JP , Sydor S , et al. Vitamin D counteracts fibrogenic TGF-beta signaling in human hepatic stellate cells both receptor-dependently and independently. Gut . 2015;64(5):64. doi:10.1136/gutjnl-2014-307024
   Web of Science ®Google Scholar
• Beilfuss A , Sowa JP , Sydor S , et al. Vitamin D counteracts fibrogenic TGF-beta signalling in human hepatic stellate cells both receptor-dependently and independently. Gut . 2015;64(5):791–799. doi:10.1136/gutjnl-2014-307024 25134788
   PubMed Web of Science ®Google Scholar
• Chalasani N , Younossi Z , Lavine JE , et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases. Hepatology . 2018;67:328–357. doi:10.1002/hep.29367 28714183
   PubMed Web of Science ®Google Scholar
• Younossi ZM , Koenig AB , Abdelatif D , et al. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology . 2016;64(1):73–84. doi:10.1002/hep.28431 26707365
   PubMed Web of Science ®Google Scholar
• Cheah MC , McCullough AJ , Goh GB . Current modalities of fibrosis assessment in non-alcoholic fatty liver disease. J Clin Transl Hepatol . 2017;5(3):261–271. doi:10.14218/JCTH.2017.00009 28936407
   PubMedGoogle Scholar
• European Association for the Study of the L, European Association for the Study of D and European Association for the Study of O. EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. J Hepatol . 2016;64(6):1388–1402. doi:10.1016/j.jhep.2015.11.004.27062661
   PubMed Web of Science ®Google Scholar
• von Elm E , Altman DG , Egger M , et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg . 2014;12(12):1495–1499. doi:10.1016/j.ijsu.2014.07.013 25046131
   PubMed Web of Science ®Google Scholar
• Guimarães RRP , Santos A , Santos A , et al. Reuse of clinical records for scientific research: legal issues related to the authorization of the holders and anonymisation. Acta Med Port . 2018;31(6):299–302. doi:10.20344/amp.10147 30020874
   PubMed Web of Science ®Google Scholar
• American Diabetes A. 2. Classification and diagnosis of diabetes: standards of medical care in Diabetes—2019. Diabetes Care . 2019;42(Supplement 1):S13–S28. doi:10.2337/dc19-S002.30559228
   PubMed Web of Science ®Google Scholar
• Williams B , Mancia G , Spiering W . 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J . 2018;39:3021–3104. doi:10.1093/eurheartj/ehy339 30165516
   PubMed Web of Science ®Google Scholar
• Expert Panel on Detection E and Treatment of High Blood Cholesterol in A. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA . 2001;285(19):2486–2497. doi:10.1001/jama.285.19.2486.11368702
   PubMed Web of Science ®Google Scholar
• Bedogni G , Bellentani S , Miglioli L , et al. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol . 2006;6(1):33. doi:10.1186/1471-230X-6-33 17081293
   PubMed Web of Science ®Google Scholar
• Holick MF , Binkley NC , Bischoff-Ferrari HA , et al. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab . 2011;96(7):1911–1930. doi:10.1210/jc.2011-0385 21646368
   PubMed Web of Science ®Google Scholar
• Eliades M , Spyrou E , Agrawal N , et al. Meta-analysis: vitamin D and non-alcoholic fatty liver disease. Aliment Pharmacol Ther . 2013;38(3):246–254. doi:10.1111/apt.12377 23786213
   PubMed Web of Science ®Google Scholar
• Liangpunsakul S , Chalasani N . Serum vitamin D concentrations and unexplained elevation in ALT among US adults. Dig Dis Sci . 2011;56(7):2124–2129. doi:10.1007/s10620-011-1707-x 21503677
   PubMed Web of Science ®Google Scholar
• Eliades M , Spyrou E . Vitamin D: a new player in non-alcoholic fatty liver disease? World J Gastroenterol . 2015;21(6):1718–1727. doi:10.3748/wjg.v21.i6.1718 25684936
   PubMed Web of Science ®Google Scholar
• Zhang Y , Jiang X , Li X , et al. Serum vitamin D levels and risk of liver cancer: a systematic review and dose-response meta-analysis of cohort studies. Nutr Cancer . 2020:1–9. doi:10.1080/01635581.2020.1797127.
   Web of Science ®Google Scholar
• Gheorghe GSA , Gaman MA , Gaman M-A , et al. The benefits and risks of antioxidant treatment in liver diseases. Rev Chim . 2019;70(2):651–655. doi:10.37358/RC.19.2.6977
   Web of Science ®Google Scholar
• Barchetta I , Angelico F , Del Ben M , et al. Strong association between non-alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC Med . 2011;9(1):85. doi:10.1186/1741-7015-9-85 21749681
   PubMed Web of Science ®Google Scholar
• Barchetta I , Carotti S , Labbadia G , et al. Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus. Hepatology . 2012;56(6):2180–2187. doi:10.1002/hep.25930 22753133
   PubMed Web of Science ®Google Scholar
• Alfadda AA , Masood A , Shaik SA , et al. Association between osteocalcin, metabolic syndrome, and cardiovascular risk factors: role of total and undercarboxylated osteocalcin in patients with type 2 diabetes. Int J Endocrinol . 2013;2013:197519. doi:10.1155/2013/197519 23653641
   PubMed Web of Science ®Google Scholar
• Abramovitch S , Sharvit E , Weisman Y , et al. Vitamin D inhibits development of liver fibrosis in an animal model but cannot ameliorate established cirrhosis. Am J Physiol Gastrointest Liver Physiol . 2015;308(2):G112–120. doi:10.1152/ajpgi.00132.2013 25214398
   PubMed Web of Science ®Google Scholar
• Bozic M , Guzman C , Benet M , et al. Hepatocyte vitamin D receptor regulates lipid metabolism and mediates experimental diet-induced steatosis. J Hepatol . 2016;65(4):748–757. doi:10.1016/j.jhep.2016.05.031 27245430
   PubMed Web of Science ®Google Scholar
• Wang N , Chen C , Zhao L , et al. Vitamin D and nonalcoholic fatty liver disease: bi-directional mendelian randomization analysis. EBioMedicine . 2018;28:187–193. doi:10.1016/j.ebiom.2017.12.027 29339098
   PubMed Web of Science ®Google Scholar
• Barchetta I , Del Ben M , Angelico F , et al. No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. BMC Med . 2016;14(1):92. doi:10.1186/s12916-016-0638-y 27353492
   PubMed Web of Science ®Google Scholar
• Han H , Cui M , You X , et al. A role of 1,25(OH)2D3 supplementation in rats with nonalcoholic steatohepatitis induced by choline-deficient diet. Nutr Metab Cardiovasc Dis . 2015;25(6):556–561. doi:10.1016/j.numecd.2015.02.011 25843661
   PubMed Web of Science ®Google Scholar
• Tabrizi R , Moosazadeh M , Lankarani KB , et al. The effects of vitamin D supplementation on metabolic profiles and liver function in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials. Diabetes Metab Syndr . 2017;11:S975–S982. doi:10.1016/j.dsx.2017.07.025 28751149
   PubMedGoogle Scholar
• Yodoshi T , Orkin S , Arce-Clachar AC , et al. Vitamin D deficiency: prevalence and association with liver disease severity in pediatric nonalcoholic fatty liver disease. Eur J Clin Nutr . 2020;74(3):427–435. doi:10.1038/s41430-019-0493-y 31444465
   PubMed Web of Science ®Google Scholar
• Papapostoli I , Lammert F , Stokes CS . Effect of short-term vitamin d correction on hepatic steatosis as quantified by controlled attenuation parameter (CAP). J Gastrointestin Liver Dis . 2016;25(2):175–181. doi:10.15403/jgld.2014.1121.252.cap 27308648
   PubMed Web of Science ®Google Scholar
• Gheorghe G , Bungau S , Ceobanu G , et al. The non-invasive assessment of hepatic fibrosis. J Formos Med Assoc . 2020. doi:10.1016/j.jfma.2020.08.019
   Web of Science ®Google Scholar
• Kaplowitz N . Drug-induced liver injury. Clin Infect Dis . 2004;38(Suppl 2):S44–48. doi:10.1086/381446 14986274
   PubMed Web of Science ®Google Scholar
• Purkins L , Love ER , Eve MD , et al. The influence of diet upon liver function tests and serum lipids in healthy male volunteers resident in a Phase I unit. Br J Clin Pharmacol . 2004;57(2):199–208. doi:10.1046/j.1365-2125.2003.01969.x 14748819
   PubMed Web of Science ®Google Scholar